BioMarin Pharmaceutical I... (BMRN)
NASDAQ: BMRN
· Real-Time Price · USD
57.53
-0.48 (-0.83%)
At close: May 23, 2025, 3:59 PM
59.00
2.55%
After-hours: May 23, 2025, 05:51 PM EDT
-0.83% (1D)
| Bid | 56.65 |
| Market Cap | 11.03B |
| Revenue (ttm) | 2.94B |
| Net Income (ttm) | 523.88M |
| EPS (ttm) | 2.7 |
| PE Ratio (ttm) | 21.31 |
| Forward PE | 13.87 |
| Analyst | Buy |
| Ask | 62 |
| Volume | 1,291,047 |
| Avg. Volume (20D) | 1,794,501 |
| Open | 57.41 |
| Previous Close | 58.01 |
| Day's Range | 57.27 - 57.79 |
| 52-Week Range | 52.93 - 94.85 |
| Beta | 0.27 |
About BMRN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BMRN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BMRN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+4.76%
BioMarin Pharma shares are trading higher after th...
Unlock content with
Pro Subscription
3 months ago
+1.16%
BioMarin Pharma shares are trading higher after the company reported better-than-expected Q4 financial results.
